Standout Papers

Safety and Immunogenicity of an Inactivated Subvirion Influenza A (H5N1) Vaccine 2006 2026 2012 2019 552
  1. Safety and Immunogenicity of an Inactivated Subvirion Influenza A (H5N1) Vaccine (2006)
    John J. Treanor, James D. Campbell et al. New England Journal of Medicine
  2. Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older Adults (2014)
    Carlos A. DiazGranados, Andrew J. Dunning et al. New England Journal of Medicine
  3. Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains (2017)
    Seth J. Zost, Kaela Parkhouse et al. Proceedings of the National Academy of Sciences

Immediate Impact

11 by Nobel laureates 33 from Science/Nature 81 standout
Sub-graph 1 of 19

Citing Papers

Influenza
2022 Standout
The Unexpected Importance of the Primary Structure of the Hydrophobic Part of One-Component Ionizable Amphiphilic Janus Dendrimers in Targeted mRNA Delivery Activity
2022 StandoutNobel
30 intermediate papers

Works of John J. Treanor being referenced

Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains
2017 Standout
Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 study
2013
and 29 more

Author Peers

Author Last Decade Papers Cites
John J. Treanor 5796 2193 2977 125 8.1k
Masato Tashiro 6006 2013 2700 166 8.1k
M. R. Hilleman 5123 1848 2541 277 9.1k
William Barclay 5629 3132 5223 206 11.7k
W. Paul Duprex 3480 1465 2531 119 6.1k
Geert van Amerongen 5743 1933 4710 159 9.2k
J.C. de Jong 6416 1177 3882 99 8.7k
Edwin D. Kilbourne 5808 1587 1486 150 7.3k
Alan P. Kendal 5126 1024 1467 140 6.1k
Martin Petric 3353 741 3359 122 6.9k
Robert B. Belshe 12033 4734 4848 255 16.5k

All Works

Loading papers...

Rankless by CCL
2026